| Date | Time | Source | Headline | Symbol | Company |
| 12/11/2014 | 4:01PM | GlobeNewswire Inc. | SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Aeterna Zentaris Inc. and Its Board of Di... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 12/11/2014 | 1:42PM | Business Wire | INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Aga... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 12/11/2014 | 11:44AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 12/10/2014 | 2:57PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 12/01/2014 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris et Sinopharm A-Think signent une entente de collaboration pour zoptaréline doxorubicine pour la Chine | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 12/01/2014 | 7:30AM | PR Newswire (US) | Aeterna Zentaris and Sinopharm A-Think Sign Master Collaboration Agreement for Zoptarelin Doxorubicin in China | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 12/01/2014 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris and Sinopharm A-Think Sign Master Collaboration Agreement for Zoptarelin Doxorubicin in China | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/25/2014 | 6:15PM | Business Wire | SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Aeterna Zentari... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/21/2014 | 12:32PM | Business Wire | SHAREHOLDER ALERT: Class Action Lawsuit Against Aeterna Zentaris Inc. Filed By Glancy Binkow & Goldberg LLP | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/20/2014 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris ajoute le Hollings Cancer Center de Charleston en Caroline du Sud à son étude clinique multinationale de p... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/20/2014 | 7:30AM | PR Newswire (US) | Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/20/2014 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/17/2014 | 10:33AM | Business Wire | Notice of Filing of Securities Fraud Class Action against Aeterna Zentaris Inc. by Abraham, Fruchter & Twersky, LLP | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/14/2014 | 1:46PM | PR Newswire (US) | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aeterna Zentaris, Inc. - AEZS | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/12/2014 | 5:10PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/12/2014 | 7:11AM | Edgar (US Regulatory) | Amended Appointment of Agent for Service of Process and Undertaking (f-x/a) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/11/2014 | 5:15PM | PR Newswire (US) | INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aeterna Zent... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/10/2014 | 10:32AM | Business Wire | INVESTOR ALERT: Investigation of Aeterna Zentaris, Inc. Announced by Glancy Binkow & Goldberg LLP | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/07/2014 | 5:08PM | Business Wire | SHAREHOLDER ALERT: Investigation on Behalf of Aeterna Zentaris, Inc. Investors Announced by Law Offices of Howard G. Smith | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/07/2014 | 11:57AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/06/2014 | 7:02PM | Business Wire | The Rosen Law Firm Announces Investigation of Securities Claims Against Aeterna Zentaris, Inc. | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/06/2014 | 7:00AM | PR Newswire (Canada) | FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen™ NDA in Adult Growth Hormone Deficiency | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/06/2014 | 7:00AM | PR Newswire (US) | FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen™ NDA in Adult Growth Hormone Deficiency | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/06/2014 | 7:00AM | PR Newswire (Canada) | La FDA émet une lettre de réponse complète à Aeterna Zentaris pour sa DNM pour Macrilen(MC) en déficience de l'hormone ... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/04/2014 | 4:44PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/04/2014 | 4:43PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/04/2014 | 4:30PM | PR Newswire (Canada) | Aeterna Zentaris annonce ses résultats financiers et d'exploitation du troisième trimestre 2014 | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/04/2014 | 4:30PM | PR Newswire (US) | Aeterna Zentaris Reports Third Quarter 2014 Financial and Operating Results | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/04/2014 | 4:30PM | PR Newswire (Canada) | Aeterna Zentaris Reports Third Quarter 2014 Financial and Operating Results | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/28/2014 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris to Announce Third Quarter 2014 Financial and Operating Results on November 4, 2014 | NASDAQ:AEZS | Aeterna Zentaris Inc |